Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders

被引:87
|
作者
Iwatsuki, K
Ohtsuka, M
Harada, H
Han, GW
Kaneko, F
机构
[1] Department of Dermatology, Fukeushima Medical College, Fukushima
[2] Department of Dermatology, Fukushima Medical College, Fukushima 960-12
关键词
D O I
10.1001/archderm.133.9.1081
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To elucidate clinicopathologic manifestations of cutaneous lymphoproliferative disorders associated with Epstein-Barr virus (EBV) infection. Design: Retrospective survey of case series. Setting: University hospital medical center. Patients: Sixty-five patients with cutaneous lymphomas and related disorders. Main Outcome Measures: Detection of EBV genes and EBV-encoded small nuclear RNAs. Results: Evidence of latent EBV infection was demonstrated in 15 patients: 3 had malignant lymphoma with clinical features mimicking cytophagic histiocytic panniculitis, 6 had facial vesiculopapular eruptions mimicking hydroa vacciniforme, 4 had angiocentric lymphoma, 1 had histiocytoid lymphoma associated with hemophagocytosis, and 1 had plasmacytoma. Hypersensitivity to mosquito bites was noted in a patient with hydroa vacciniforme-like eruptions and another with histiocytoid lymphoma. Angiocentric infiltration of atypical lymphoid cells was a common histological feature in the patients with hydroa vacciniforme-like eruptions and angiocentric lymphoma. No evidence of EBV infection was apparent in 19 patients with mycosis fungoides or Sezary syndrome, 7 with adult T-cell leukemia or lymphoma, 3 with lymphomatoid papulosis (type A), and 2 with lymphocytoma cutis. Conclusion: Patients with EBV-associated cutaneous lymphoproliferative disorders present with unique and diagnostic clinicopathologic features distinct from those of mycosis fungoides or Sezary syndrome.
引用
收藏
页码:1081 / 1086
页数:6
相关论文
共 50 条
  • [1] EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS
    PURTILO, DT
    STROBACH, RS
    OKANO, M
    DAVIS, JR
    [J]. LABORATORY INVESTIGATION, 1992, 67 (01) : 5 - 23
  • [2] Epstein-Barr virus-associated lymphoproliferative disorders
    Grywalska, Ewelina
    Markowicz, Justyna
    Grabarczyk, Piotr
    Pasiarski, Marcin
    Rolinski, Jacek
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 481 - 490
  • [3] Epstein-Barr virus-associated lymphoproliferative disorders
    Rezk, Sherif A.
    Weiss, Lawrence M.
    [J]. HUMAN PATHOLOGY, 2007, 38 (09) : 1293 - 1304
  • [4] EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS
    SCHUSTER, V
    KRETH, HW
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 1991, 139 (07) : 396 - 400
  • [5] MANIFESTATIONS OF EPSTEIN-BARR VIRUS-ASSOCIATED DISORDERS IN LIVER
    MARKIN, RS
    [J]. LIVER, 1994, 14 (01): : 1 - 13
  • [6] Treatment of Epstein-Barr virus-associated posttransplant lymphoproliferative disorders
    Gross, TG
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (01) : 7 - 9
  • [7] EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN IMMUNOCOMPROMISED INDIVIDUALS
    THOMAS, JA
    ALLDAY, MJ
    CRAWFORD, DH
    [J]. ADVANCES IN CANCER RESEARCH, 1991, 57 : 329 - 380
  • [8] Localized cutaneous posttransplant Epstein-Barr virus-associated lymphoproliferative disorder
    Capaldi, L
    Robinson-Bostom, L
    Kerr, P
    Gohh, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (05) : 778 - 780
  • [9] Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments
    Geng, Lingyun
    Wang, Xin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 14656 - 14671
  • [10] Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders
    Yang, Xi
    Nishida, Naonori
    Zhao, Xiaodong
    Kanegane, Hirokazu
    [J]. IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2015, 14 (05) : 462 - 471